OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-55 Cr | ₹-9.59 Cr | ₹-7.89 Cr | ₹1.50 Cr | ₹-1.55 Cr |
What is the latest Net Current Assets ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-55 Cr |
| Mar2024 | ₹-9.59 Cr |
| Mar2023 | ₹-7.89 Cr |
| Mar2022 | ₹1.50 Cr |
| Mar2021 | ₹-1.55 Cr |
How is Net Current Assets of OXYGENTA PHARMACEUTICAL Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-55 Cr | Negative | |
| Mar2024 | ₹-9.59 Cr | Negative | |
| Mar2023 | ₹-7.89 Cr | Negative | |
| Mar2022 | ₹1.50 Cr | Positive | |
| Mar2021 | ₹-1.55 Cr | - | |
Compare Net Current Assets of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹180.3 Cr | -1.4% | -7.6% | -37.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -1.4% |
-7.6% |
-37.6% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses